Education
About Us
Working with TipRanks
Follow Us
Transgene SA (GB:0OCQ)
LSE:0OCQ
Tg6050
Non-small Cell Lung Cancer
Phase I
Terminated
A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)
Mar 15, 2023
―
Tg4050
Squamous Cell Carcinoma Of Head And Neck
Phase I/II
Active Not Recruiting
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
Nov 21, 2019
―
Tg4050
Fallopian Tube Cancer, Ovarian Carcinoma, Peritoneal Carcinoma
Phase I
Completed
A Trial Evaluating TG4050 in Ovarian Carcinoma.
Feb 06, 2019
―
Avelumab, Tg4001
Hpv-Related Cervical Carcinoma, Hpv-Related Carcinoma, Hpv-Related Anal Squamous Cell Carcinoma, Hpv-Related Penile Squamous Cell Carcinoma, Hpv-Related Vulvar Squamous Cell Carcinoma
Phase I/II
Active Not Recruiting
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
Aug 17, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Transgene SA (0OCQ) have in its pipeline
0OCQ is currently developing the following drugs: Tg6050, Tg4050, Tg4050. These drug candidates are in various stages of clinical development as the company works toward FDA approval.